Picture of Ryvu Therapeutics SA logo

RVU Ryvu Therapeutics SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Ryvu Therapeutics Says That BioNTech Terminated STING Program

January 30 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * SAID ON WEDNESDAY THAT BIONTECH HAS TERMINATED "STING"
PROGRAM
AND TWO OTHER PROGRAMS
    * AFTER TERMINATION RYVU THERAPEUTICS TO REGAIN FULL RIGHTS
TO THE
PROGRAM
    * BIONTECH TO FINANCE ALL R&D COSTS IN ONGOING COLLABORATION
WITH
RYVU

        
 Source text:  urn:newsml:reuters.com:*:nEM4wdVJda
 Further company coverage:  RVU.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Ryvu Therapeutics SA

See all news